Cite
HARVARD Citation
Karathanos, C. et al. (2023). Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin. Phlebology. pp. 141-149. [Online].